Bosh sahifa069620 • KRX
add
Daewoong Pharma
Yopilish kursi
129 000,00 ₩
Kunlik diapazon
127 300,00 ₩ - 130 800,00 ₩
Yillik diapazon
100 100,00 ₩ - 164 400,00 ₩
Bozor kapitalizatsiyasi
1,50 trln KRW
Oʻrtacha hajm
40,40 ming
Narx/foyda
14,34
Dividend daromadliligi
0,46%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 358,47 mlrd | 5,16% |
Joriy xarajat | 144,74 mlrd | 7,00% |
Sof foyda | 28,28 mlrd | 81,53% |
Sof foyda marjasi | 7,89 | 72,65% |
Har bir ulushga tushum | — | — |
EBITDA | 49,20 mlrd | 21,91% |
Amaldagi soliq stavkasi | -3,14% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 107,51 mlrd | -37,49% |
Jami aktivlari | 1,92 trln | 12,48% |
Jami passivlari | 971,10 mlrd | 13,73% |
Umumiy kapital | 951,35 mlrd | — |
Tarqatilgan aksiyalar | 11,51 mln | — |
Narxi/balansdagi bahosi | 1,82 | — |
Aktivlardan daromad | 4,90% | — |
Kapitaldan daromad | 6,10% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 28,28 mlrd | 81,53% |
Operatsiyalardan naqd pul | 22,21 mlrd | -65,56% |
Sarmoyadan naqd pul | -51,68 mlrd | -61,59% |
Moliyadan naqd pul | 36,58 mlrd | 3 410,29% |
Naqd pulning sof oʻzgarishi | 6,89 mlrd | -77,97% |
Boʻsh pul | -35,44 mlrd | -283,86% |
Haqida
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Tashkil etilgan
1945
Sayt
Xodimlar soni
1 715
